top of page
Image by Sasun Bughdaryan

Striving to Prevent Damage from Chemotherapy

Welcome to Eisana Health

Up to 500,000 cancer patients a year develop chemotherapy-induced peripheral neuropathy (CIPN), which is permanent nerve damage in the hands and feet. Eisana Health is developing the first patient-centered cooling device designed to prevent it.

Surviving Cancer Shouldn't Mean a Life of Pain

Eisana Health is an early-stage medical device company founded in 2020 by Dr. Carole Spangler Vaughn, a life sciences veteran, oncology entrepreneur, and cancer survivor. 

After her own Stage 2b breast cancer diagnosis, Carole was stunned to discover that one of the most common and devastating side effects of chemotherapy is nerve damage in the hands and feet, which is largely preventable with cooling, yet no practical solution existed for patients. 

She founded Eisana Health to change that. Unnecessary pain and suffering should never be the price of survival. 

Family Walking Beach

Chemotherapy-Induced Peripheral Neuropathy

 

CIPN is nerve damage caused by many common chemotherapy drugs. It affects the nerve endings in the fingers and toes, and for hundreds of thousands of patients each year, it's permanent. 

Hands Holding Foot
Image by Imani Bahati
Elderly Support Interaction

Hands & Feet

No Cure

Quality of Life

CIPN targets peripheral nerves, causing numbness, burning, and shooting pain in fingers and toes.

Once it develops, CIPN is often irreversible. Prevention is the most effective strategy available.

Patients lose fine motor skills, mobility, and independence, which affects daily life long after treatment ends. 

Watch how our cooling device helps prevent CIPN.

Who We're Here For

The Eisana Health cooling system includes cooling gloves, cooling booties, and a portable chiller, all designed so patients maintain dignity, comfort, and independence throughout their chemotherapy treatment day. 

Patients & Caregivers

Learn about CIPN, understand the risk, and explore how cooling therapy can help protect hands and feet during treatment.

Clinical Researchers

Explore the clinical evidence behind cryotherapy for CIPN prevention, or reach out to discuss participation in product trials. 

Investors & Supporters

Join us in bringing the cooling device system to patients. Support our crowdfunding campaign.

Caregiver Assisting Man

Our Product

Finally, a Device Designed for the Patient

Works at Home

Portable design extends cooling beyond the infusion center, where compliance matters most. 

Hands Stay Functional

Conductive fingertips let patiencts use a phone, eat, and read while the device works. 

8+ Hours of Cooling

Continuous, gentle cooling from clinic through getting home for the total time the chemo drug is still at high levels in the patient's system. 

bottom of page